ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.

Jennifer N Brudno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.